Ico Rene Gauducheau

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer3 trials
• Lung cancer3 trials
• Cervical cancer1 trial
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Melanoma1 trial
• Prostate cancer1 trial
• Sarcoma1 trial

Phase

• Phase 25 trials
• Phase 11 trial
• Phase 31 trial

Status

• Completed8 trials
• Recruiting1 trial

Lead sponsor

• Hoffmann-La Roche4 trials
• Institut Cancerologie de l'Ouest2 trials
• Canadian Cancer Trials Group1 trial
• Centre Leon Berard1 trial
• Centre Oscar Lambret1 trial

Running trials

• Recruiting

  Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

  NCT04698785· Phase 2· Centre Leon Berard· Source

  Contact: Emmanuelle BOMPAS

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Sarcoma1 recruiting

Closed trials

• Completed

  A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer

  NCT05775289· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus

  NCT04785820· Phase 2· Hoffmann-La Roche· Source

• Completed

  Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer

  NCT04323722· Institut Cancerologie de l'Ouest· Source

• Completed

  A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT03735121· Phase 3· Hoffmann-La Roche· Source

• Completed

  A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors

  NCT03708328· Phase 1· Hoffmann-La Roche· Source

• Completed

  PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer

  NCT02359968· Phase 2· Centre Oscar Lambret· Source

• Completed

  Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer

  NCT02274779· Phase 2· Institut Cancerologie de l'Ouest· Source

• Completed

  Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

  NCT01658930· Canadian Cancer Trials Group· Source